Filippatos TD, Elisaf MS. Role of ezetimibe in non-alcoholic fatty liver disease. World J Hepatology 2011; 3(10): 265-267 [PMID: 22059109 DOI: 10.4254/wjh.v3.i10.265]
Corresponding Author of This Article
Moses S Elisaf, MD, FRSH, FASAA, Professor of Medicine, Department of Internal Medicine, School of Medicine, University of Ioannina, 45110 Ioannina, Greece. egepi@cc.uoi.gr
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/